Coagulation: Consultative Hemostasis
Open Access
- 1 January 2002
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2002 (1), 335-352
- https://doi.org/10.1182/asheducation-2002.1.335
Abstract
Clinical hematologists are frequently consulted for the care of hospitalized patients with complicated coagulopathies. This chapter provides an update on the scientific and clinical advances noted in disseminated intravascular coagulation (DIC) and discusses the challenges in hemostasis consultation. In Section I, Dr. Marcel Levi reviews advances in our understanding of the pathogenic mechanisms of DIC. Novel therapeutic strategies that have been developed and evaluated in patients with DIC are discussed, as are the clinical trials performed in patients with sepsis. In Section II, Dr. Lawrence Leung provides an overview of the challenging problems in thrombosis encountered in the inpatient setting. Patients with deep vein thrombosis that is refractory to conventional anticoagulation and those with extensive mesenteric thrombosis as well as the evaluation of a positive PF4/heparin ELISA in a post-operative setting are discussed. Novel treatments for recurrent catheter thrombosis in dialysis patients is addressed as well. In Section III, Dr. Julie Hambleton reviews the hemostatic complications of solid organ transplantation. Coagulopathy associated with liver transplantation, contribution of underlying thrombophilia to graft thrombosis, drug-induced microangiopathy, and the indication for postoperative prophylaxis are emphasized. Dr. Hambleton reviews the clinical trials evaluating hemostatic agents in patients undergoing liver transplantation.Keywords
This publication has 96 references indexed in Scilit:
- Disseminated Intravascular Coagulation in Trauma PatientsSeminars in Thrombosis and Hemostasis, 2001
- Dysfunction of Endothelial Protein C Activation in Severe Meningococcal SepsisNew England Journal of Medicine, 2001
- Natural history of arteriovenous grafts in hemodialysis patientsAmerican Journal of Kidney Diseases, 2000
- Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulationAmerican Journal of Hematology, 1997
- Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulationCritical Care Medicine, 1995
- Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosisKidney International, 1995
- REDUCED FIBRINOLYTIC POTENTIAL ONE YEAR AFTER KIDNEY TRANSPLANTATIONTransplantation, 1995
- Assessment of hypercoagulable states by measurement of activation fragments and peptidesBlood Reviews, 1990
- ALLOGRAFT RENAL VASCULAR THROMBOSIS-LACK OF INCREASE WITH CYCLOSPORINE IMMUNOSUPPRESSIONTransplantation, 1989
- Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.JCI Insight, 1987